How to buy Trevena stock

Trevena, Inc is a biotechnology business based in the US. Trevena shares (TRVN) are listed on the NASDAQ and all prices are listed in US Dollars. Trevena employs 24 staff and has a trailing 12-month revenue of around USD$3 million.

How to buy shares in Trevena

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for Trevena. Find the stock by name or ticker symbol: TRVN. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Trevena reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Trevena, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of Trevena. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Our top pick for

Beginners

Robinhood

Our top pick for

Building a portfolio

Sofi Invest

Our top pick for

Advanced traders

Interactive Brokers

How we chose our top picks

We evaluate stock trading platforms against a range of metrics that include fees, ease of use, available securities and advanced tools to meet specific investor needs. We encourage you to compare stock platforms to find one that's best for your particular budget and goals.

• Our pick for beginners. We chose Robinhood for this category because it offers commission-free trading and is easy to use. You can search for stocks by company name, and the mobile app is clean and intuitive to use.
• Our pick for building a portfolio. We chose SoFi for this category because it offers both commission-free stocks and a free robo-advisor. That means you can open an active investing account to pick and choose companies you want to invest in, and open a robo-advisor account to help you build a portfolio and manage how much risk you take on.
• Our pick for active traders. We picked Interactive Brokers for this category because it offers advanced tools and low fees for active investors and pros. The simpler IBKR Lite platform is aimed at less-active investors, but all users older than 21 must meet a $20,000 liquid net worth requirement for a cash account.

What's in this guide?

1. TRVN shares summary
2. Compare share dealing platforms
3. Is TRVN stock a buy or sell?
4. Stock performance over time
5. Can I short TRVN shares?
6. Trevena's financials
7. How volatile are TRVN shares?
8. Does Trevena pay a dividend?
9. Other common questions

Trevena share price

Use our graph to track the performance of TRVN stocks over time.

Trevena shares at a glance

• Key figures

Information last updated 2021-02-24.

52-week range	USD$0.46 - USD$3.68
50-day moving average	USD$2.3652
200-day moving average	USD$2.396
Wall St. target price	USD$5.25
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	USD$-0.262

Buy Trevena shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Sort by:

Name	Product	Stock trade fee	Asset types	Option trade fee	Annual fee	Signup bonus
Robinhood		$0	Stocks, Options, ETFs, Gold/Commodities	$0	0%	Free stock (chosen randomly with a value anywhere between $2.50 and $200) Sign up using the "go to site" link	Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.	Go to site More Info		loading Fetching your data...
Interactive Brokers		$0	Stocks, Bonds, Options	$0 + $0.65/contract, $1 minimum	0%	N/A	IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.	Go to site More Info		loading Fetching your data...
Tastyworks		$0	Stocks, Options, Cryptocurrency	Stocks & ETFs: $1/contract to open, $0 to close, $10 max/leg Futures: $2.50/contract to open, $0 to close	0%	Get 100 shares of stock (worth $1 to $6 a share) Open and fund a new cash or margin account with $2,000+	Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.	Go to site More Info		loading Fetching your data...
Moomoo		$0 for US stocks	Stocks, Options, ETFs	$0		N/A	Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.	Go to site More Info		loading Fetching your data...
TradeStation		$0	Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency	$0 + $0.50/contract		$50 Deposit qualifying assets of $5,000+	A platform built for all kinds of traders and all styles of trading	Go to site More Info		loading Fetching your data...

loading

Compare up to 4 providers

Clear selection

Compare

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Trevena stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Trevena, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Shorting Trevena shares

There are currently 22.0 million Trevena shares held short by investors – that's known as Trevena's "short interest". This figure is 0.8% down from 22.2 million last month.

There are a few different ways that this level of interest in shorting Trevena shares can be evaluated.

Trevena's "short interest ratio" (SIR)

Trevena's "short interest ratio" (SIR) is the quantity of Trevena shares currently shorted divided by the average quantity of Trevena shares traded daily (recently around 3.2 million). Trevena's SIR currently stands at 6.88. In other words for every 100,000 Trevena shares traded daily on the market, roughly 6880 shares are currently held short.

However Trevena's short interest can also be evaluated against the total number of Trevena shares, or, against the total number of tradable Trevena shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Trevena's short interest could be expressed as 0.14% of the outstanding shares (for every 100,000 Trevena shares in existence, roughly 140 shares are currently held short) or 0.141% of the tradable shares (for every 100,000 tradable Trevena shares, roughly 141 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Trevena.

Find out more about how you can short Trevena stock.

Trevena share price volatility

Over the last 12 months, Trevena's shares have ranged in value from as little as $0.46 up to $3.68. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Trevena's is 2.5203. This would suggest that Trevena's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Trevena overview

Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its product candidates include Oliceridine injection, a G protein biased mu-opioid receptor (MOR) ligand that has completed Phase III clinical trials for the management of moderate-to-severe acute pain where intravenous administration is warranted; TRV250, a G protein biased delta-opioid receptor agonist that has completed Phase I clinical study for the treatment of acute migraine; TRV734, a small molecule G protein biased ligand of the MOR that has completed Phase I clinical study for the treatment of moderate-to-severe acute and chronic pain; TRV027 for the treatment of acute heart failure; and TRV045, a novel S1P modulator for managing chronic pain. The company has a collaboration with Imperial College London to evaluate Trv027 in Covid-19 patients. Trevena, Inc. was founded in 2007 and is headquartered in Chesterbrook, Pennsylvania.

Frequently asked questions

• What percentage of Trevena is owned by insiders or institutions?

  Currently 1.58% of Trevena shares are held by insiders and 11.653% by institutions.

• How many people work for Trevena?

  Latest data suggests 24 work at Trevena.

• When does the fiscal year end for Trevena?

  Trevena's fiscal year ends in December.

• Where is Trevena based?

  Trevena's address is: 955 Chesterbrook Boulevard, Chesterbrook, PA, United States, 19087

• What is Trevena's ISIN number?

  Trevena's international securities identification number is: US89532E1091

• What is Trevena's CUSIP number?

  Trevena's Committee on Uniform Securities Identification Procedures number is: 89532E109